CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 17 filers reported holding CATALYST BIOSCIENCES INC in Q1 2017. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $962,000 | -0.9% | 201,265 | -5.2% | 0.00% | – |
| Q2 2021 | $971,000 | +20.6% | 212,398 | +36.5% | 0.00% | -100.0% |
| Q1 2021 | $805,000 | -11.0% | 155,609 | +11.1% | 0.00% | 0.0% |
| Q4 2020 | $904,000 | +17980.0% | 140,107 | +13595.7% | 0.00% | – |
| Q3 2020 | $5,000 | -50.0% | 1,023 | -39.3% | 0.00% | – |
| Q2 2020 | $10,000 | – | 1,686 | +10437.5% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 16 | -90.5% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 168 | +104.9% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 82 | -2.4% | 0.00% | – |
| Q2 2018 | $1,000 | -98.8% | 84 | -99.0% | 0.00% | – |
| Q1 2017 | $80,000 | – | 8,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
| 22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
| Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
| Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
| Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
| AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
| Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
| Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |